Nifuroxazide (INN) is an oral nitrofuran antibiotic, patented since 1966[1] and used to treat colitis and diarrhea in humans and non-humans.[2] It is sold under the brand names Ambatrol, Antinal, Bacifurane, Diafuryl, Pérabacticel (France), Antinal, Diax (Egypt), Nifrozid, Ercefuryl (Romania, Czech Republic), Erfuzide (Thailand), Endiex (Slovakia), Enterofuryl (Russia), Nifuroksazyd (Poland), Pentofuryl (Germany), Topron, Enterovid (Latin America), Eskapar (Mexico), Apazid (Morocco) and Septidiaryl. It is sold in capsule form and also as a suspension. The pharmaceutical group GlaxoSmithKline plc (Previously known as SmithKline Beecham) claims that nifuroxazide is highly effective and the consumers' group Healthy Skepticism says that GlaxoSmithKline's claims have no scientific support.[3]
Starting at
4-Hydroxy-N’-[(5-nitrofuran-2-yl)methylene]benzohydrazide |
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral |
CAS Number | 965-52-6 |
ATC code | A07AX03 |
PubChem | CID: 5337997 |
ChemSpider | 4495115 |
UNII | PM5LI0P38J |
KEGG | D07111 |
ChEMBL | CHEMBL244888 |
Formula | C12H9N3O5 |
Molecular mass | 275.2 g/mol |
SMILES[show] |
|
InChI[show] |
Reviews
There are no reviews yet.